About this trial
The vast majority of the 36.2 million individuals admitted to U.S. hospitals are diagnosed with hypertension and experience an elevated blood pressure (BP) reading during hospitalization. There are no guidelines for managing asymptomatically elevated BPs in the inpatient setting, and growing observational evidence suggests that antihypertensive medication intensification increases harm. The proposed study tests whether a unit-based intervention (ACT-BP) can reduce antihypertensive medication intensification and provides information that is scientifically necessary for designing a cluster-randomized clinical trial that identifies the impact of intensification after experiencing an asymptomatically elevated BP on patient outcomes.
Eligibility criteria
Qualifiers
At the unit level: Medical units that do not typically care for patients requiring step-down care.
Disqualifiers
Patients less than 18
Patients experiencing hypertensive emergencies or cardiac symptoms
Patients with active cardiovascular events, such as
Stroke
Trial design
Treatments tested in this trial
- ACT-BP Intervention
Treatment groups
Sponsors and collaborators
Elizabeth Pfoh
Lead sponsor
The Cleveland Clinic
Sponsor institution
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator